BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Dr. Arnold Levine Joins GeneCentric Diagnostics Board of Directors


9/26/2012 9:45:44 AM

DURHAM, N.C., Sept. 26, 2012 /PRNewswire/ -- GeneCentric, a molecular diagnostics company focused on personalized oncology today announced the appointment of Dr. Arnold Levine to the company's board of directors. Dr. Levine brings to GeneCentric a wealth of experience related to the life sciences, and status as a prominent inventor in the field of molecular biology.

"I am pleased to join the GeneCentric Board at this important time for both the company and personalized oncology," said Dr. Levine. "GeneCentric has brought together world leaders in cancer research and diagnostics. They have made tremendous progress in a very short amount of time to advance the development of novel, targeted assays that enable oncologists make more informed, individualized, therapy decisions."

Dr. Levine is a widely acclaimed leader in cancer research. In 1979, Levine and others discovered the p53 tumor suppressor protein, a molecule that inhibits tumor development. Dr. Levine previously served as President and Chief Executive Officer of Rockefeller University from 1998 to 2002 and was the Harry C. Weiss Professor of the Life Sciences and Chairman of the Molecular Biology Department at Princeton University from 1984 to 1998. He established the Simons Center for Systems Biology at the Institute for Advanced Study, which concentrates on research at the interface of molecular biology and the physical sciences: on genetics and genomics, polymorphisms and molecular aspects of evolution, signal transduction pathways and networks, stress responses, and pharmacogenomics in cancer biology.

"We are excited to have Dr. Levine join the GeneCentric board. HIs vast experience will help drive the GeneCentric scientific vision and strategy," said Clay Thorp, General Partner at Hatteras Venture Partners and Chairman of GeneCentric. "The addition of Dr. Levine further validates both the company's scientific and development strategies."

GeneCentric was co-founded in 2011 by two pioneers in cancer research, Drs. Charles Perou and Neil Hayes, who discovered molecular signatures critical in distinguishing clinically relevant subtypes of lung cancer. GeneCentric in-licensed from UNC-CH these technologies, known as the Lung Subtype Platform (LSP), and the Hypoxia Signature for diagnosing risk of cancer metastasis, and Hatteras Venture Partners provided the founding Series I financing. GeneCentric is led by Dr. Myla Lai-Goldman, former CMO & CSO of Laboratory Corporation of America, Holdings (LabCorp) and current Venture Partner at Hatteras Venture Partners.

About GeneCentric

GeneCentric Diagnostics, Inc, based in Durham, NC, is a molecular diagnostic company which develops and commercializes novel assays that enable oncologists and their patients make more informed treatment decisions. For more information, please visit: www.genecentric.com


Contact:

Myla Lai-Goldman
myla@genecentric.com

SOURCE GeneCentric


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->